VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ORMP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ORMPOramed Pharmaceuticals Inc.
$4.49$184M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksORMPQuarterly Balance Sheet

Oramed Pharmaceuticals Inc. (ORMP) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Oramed Pharmaceuticals Inc. (ORMP) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

ORMP Balance Sheet

Quarterly statement

ORMP Balance Sheet

Oramed Pharmaceuticals Inc. (ORMP) balance sheet — 22-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets53.41M68.15M133.27M136.12M99.03M131.48M143.22M142.77M153.27M177.09M162.58M175.71M150.97M155.16M157.11M160.17M134.87M143.56M152.33M95.34M
Cash & Short-Term Investments50.61M65.84M125.89M134.69M97.94M130.64M141.93M142.3M152.74M176.59M162.05M175.04M150.2M153.73M155.72M159.55M133.91M141.61M150.53M94.14M
Cash Only15.24M13.2M45.95M52.18M15.8M74.52M54.42M42.1M84.75M18.58M9.05M5.47M6.77M24.1M40.46M33.2M29.89M27.97M31.88M77.25M
Short-Term Investments35.37M52.64M79.95M82.51M82.14M56.13M87.51M100.2M67.98M158.02M152.99M169.57M143.43M129.63M115.26M126.35M104.02M113.64M118.66M16.89M
Accounts Receivable622K04.64M00000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets2.17M2.31M2.74M1.43M1.09M832K1.29M474K533K501K537K666K769K1.42M1.39M623K958K1.95M1.8M1.2M
Total Non-Current Assets316.24M200.7M97.59M84.38M62.66M16.06M12.06M22.31M30.95M26.56M57.97M55.19M5.34M4.62M4.53M4.26M27.42M28.66M30.12M32.66M
Property, Plant & Equipment1.15M1.25M1.34M1.43M3.48M2.23M1.11M1.2M1.33M1.43M1.57M1.69M1.79M1.89M1.81M1.54M1.5M1.53M889K932K
Fixed Asset Turnover-----1.20x------0.37x0.36x0.41x0.45x0.44x0.55x0.74x0.73x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments315.04M199.4M93.74M79.74M56.61M9.53M10.91M21.07M29.59M25.09M56.37M53.47M3.52M2.7M2.7M2.7M684K1.96M4.13M6.69M
Other Non-Current Assets51K48K2.52M3.21M2.57M4.3M34K32K30K36K34K-55.16M33K31K24K25K25.23M25.18M25.1M25.04M
Total Assets369.64M268.85M230.86M220.49M161.68M147.54M155.28M165.08M184.22M203.65M220.55M230.89M156.31M159.78M161.64M164.44M162.29M172.22M182.45M128M
Asset Turnover-----0.01x------0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.01x
Asset Growth %128.62%82.22%48.68%33.57%-12.23%-27.55%-29.6%-28.5%17.85%27.46%36.44%40.41%-3.68%-7.23%-11.4%28.47%101.62%179.33%345.31%186.78%
Total Current Liabilities10.73M10.56M19.09M6.12M3.69M5.49M5.68M5.27M3.73M33.56M53.21M78.17M1.07M4.97M5.75M6.53M6.42M6.32M7.66M6.68M
Accounts Payable374K481K443K560K715K509K789K5M3.48M1.27M551K2.56M828K4.05M2.17M4.21M3.48M3.31M4.76M2.61M
Days Payables Outstanding-1.39K-1.89K-29.48.58K-------------
Short-Term Debt249K268K285K271K264K181K00032.03M51.01M75.61M236K242K247K228K233K237K130K130K
Deferred Revenue (Current)1.71M1.47M1.35M986K1.24M0000004M4M674K1.34M2.02M2.7M2.7M2.7M2.7M
Other Current Liabilities1.78M3.23M12.96M586K875K836K1.07M35K01K325K-6.56M-4.83M-4.05M-191K-4.13M-3.48M-3.24M-4.7M-1.37M
Current Ratio4.98x6.45x6.98x22.24x26.81x23.94x25.19x27.08x41.06x5.28x3.06x2.25x141.49x31.21x27.34x24.55x21.01x22.70x19.89x14.27x
Quick Ratio4.98x6.45x6.98x22.24x26.81x23.94x25.19x27.08x41.06x5.28x3.06x2.25x141.49x31.21x27.34x24.55x21.01x22.70x19.89x14.27x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities41.44M20.01M12.03M12.04M4.41M2.15M4.25M4.29M4.34M4.38M4.44M4.49M4.59M4.66M4.74M4.76M2.84M3.68M4.1M4.8M
Long-Term Debt00000000000389K488K564K647K672K744K871K374K403K
Capital Lease Obligations484K493K540K589K648K120K156K186K236K272K342K000000000
Deferred Tax Liabilities39.54M17.75M7.91M7.92M000000011K11K11K11K11K11K11K11K11K
Other Non-Current Liabilities202K238K314K38K36K33K90K4.1M100K103K102K88K93K85K82K82K81K121K144K145K
Total Liabilities52.17M30.57M31.12M18.16M8.1M7.64M9.93M9.56M8.07M37.93M57.66M82.66M5.66M9.63M10.49M11.29M9.25M10M11.76M11.48M
Total Debt733K761K825K860K912K301K372K429K486K32.56M51.62M76M724K806K894K900K977K1.11M504K533K
Net Debt-14.51M-12.44M-45.12M-51.32M-14.88M-74.22M-54.05M-41.67M-84.27M13.98M42.57M70.53M-6.04M-23.3M-39.57M-32.3M-28.91M-26.86M-31.38M-76.71M
Debt / Equity0.00x0.00x0.00x0.00x0.01x0.00x0.00x0.00x0.00x0.20x0.32x0.51x0.00x0.01x0.01x0.01x0.01x0.01x0.00x0.00x
Debt / EBITDA0.01x-------------------
Net Debt / EBITDA-0.14x-------------------
Interest Coverage--29.07x---1.76x-0.63x-0.20x42.52x3.59x11.98x-3.50x----7.90x-32.62x-20.68x-46.06x-
Total Equity317.47M238.28M199.74M202.33M153.58M139.89M145.35M155.52M176.15M165.72M162.89M148.23M150.66M150.15M151.16M153.15M153.04M162.22M170.69M116.52M
Equity Growth %106.71%70.33%37.43%30.1%-12.81%-15.58%-10.77%4.92%16.93%10.37%7.76%-3.21%-1.56%-7.44%-11.44%31.44%121.17%228.11%505.03%254.38%
Book Value per Share7.475.684.714.733.603.393.643.804.243.994.023.663.753.753.883.923.944.194.653.89
Total Shareholders' Equity317.47M238.28M199.74M203.28M154.53M140.81M146.26M156.44M177.06M166.64M163.82M149.13M151.55M150.97M151.81M153.81M153.7M162.35M170.16M115.77M
Common Stock495K491K472K490K491K491K480K484K488K487K485K484K484K481K476K470K463K463K458K424K
Retained Earnings-6.96M-85.12M-123.44M-122.58M-170.97M-184.26M-176.62M-166.43M-146.81M-156.02M-157.56M-170.89M-167.67M-166.48M-163.08M-154.54M-147.48M-136.94M-122.74M-114.85M
Treasury Stock00000000000---------
Accumulated OCI00000000000000000000
Minority Interest000-952K-946K-918K-918K-919K-911K-918K-928K-902K-891K-822K-656K-661K-660K-126K536K744K